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Blood lipid consists of cholesterol, triglyceride, phospholipid, and free fatty acid
(FFA). These flow through the blood vessels in the form of lipoprotein. Hyper-
lipidemia designates the case where lipids are not normally transported due to the
problems in lipoprotein synthesis and analysis. Hyperlipidemia is a key factor of
arteriosclerosis, a pathophysiologic factor of vascular diseases such as angina
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Purpose: Atherosclerosis is characterized by the progressive deposition of lipids
and inflammatory process. We attempted to develop a chemically-induced hyper-
lipidemic mice model, using poloxamer-407 and evaluated the lipid lowering and
anti-inflammatory effect of P. notoginseng compared with that of atorvastatin, an
antihyperlipidemic drug. Materials and Methods: Male Wistar rats were ran-
domly divided into 5 groups: control group without any intervention (normal),
poloxamer 500 mg/kg i.p. (P),  poloxamer plus atorvastatin 1.34 mg/kg p.o. (P +
ST), poloxamer plus P. notoginseng 40 mg/kg p.o. (P + NG40), and poloxamer
plus P. notoginseng 100 mg/kg p.o. (P + NG100). After 3 weeks, we measured
serum total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein
(HDL), triglyceride, interleukin (IL)-1, tumor necrosis factor (TNF)-α levels, and
reports of cyclo-oxygenase (COX)-2 & intercellular adhesion molecule (ICAM)
appearances in each group. Results: After 3 weeks, serum cholesterol levels signi-
ficantly decreased in P + ST and P + NG40 groups. Significant decrease of LDL
level was only noted in the P + ST group. P + ST, P + NG40, and P + NG100 also
had decreased serum triglyceride levels; however, P + ST and P + NG40 showed
no statistical difference of the triglyceride lowering effect. The results of IL-1 and
TNF-α and the appearance of COX-2 and ICAM were statistically not different in
each group. Conclusion: P. notoginseng 40 mg/kg showed significantly lowering
effects on serum total cholesterol and triglyceride levels. We suggest a well-de-
signed study showing the effects of regulating blood lipids with combined admini-
stration of P. notoginseng and statin-drug. 
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INTRODUCTIONpectoris, myocardial infarction, and stroke. Thus, it is very
important to properly maintain the blood-lipid concentra-
tion in the prevention and early treatment of hyperlipide-
mia.
1,2 
In light of traditional Korean medicine, hyperlipidemia
designates the case where blood becomes smeary and
clotted, which is related with obesity, circulatory disorders,
metabolic disorders, intracorporal clamminess, intracor-
poral heat, circulatory congestion and otherwise defined by
traditional Korean medicine. Also, symptoms such as
bacterial hematic fever, bloody sweat, anemic condition,
and exhaustion of vital energy are regarded as the etiology.
To be brief, in light of traditional Korean medicine, hyper-
lipidemia is closely related with the disharmony among the
spleen, the heart, the liver, and the kidney. From the view-
point of modern medical science, hyperlipidemia indicates
when blood-lipid concentration is in the top 10%. Such a
symptom can be explained under the category of abnormal
body wastes and blood congestion in traditional Korean
medicine.
3
Sam-Chil-Geun [Panax notoginseng (Burk) F. H. Chen]
is similar to ginseng. It is not indigenous to Korea, but to
China.
4 It has been traditionally used as both internal medi-
cine and also external preparation against blood congestion
and extravasation. Also, it helps circulate blood, decongest
blood circulation, treat inflammations, and relieve pain.
Moreover, it has been recently reported that Sam-Chil-
Geun is effective against the angina pectoris caused by
coronary arteriosclerosis. Since Sam-Chil-Geun is effective
in decongesting blood circulation, the above result might
be possible.
5 This suggests that hyperlipidemia may be
treated in traditional Korean medicine, along with Sam-
Chil-Geun.
Recently, Park and Wang
6 reported that the mixture of
the musk, the ox bezoar, and Sam-Chil-Geun significantly
lowered the total cholesterol, phospholipids, and low-
density lipoprotein (LDL)-cholesterol of rabbits with hy-
perlipidemia induced by high-cholesterol diets. Likewise,
Kim
7 reported that the Sam-Chil-Geun extract significantly
lowered the total cholesterol, LDL-cholesterol, and trigly-
ceride of the rats with hyperlipidemia induced by high-
cholesterol diets. In addition, it was reported that anti-in-
flammatory treatment may be effective against hyperlipi-
demia because hyperlipidemia is closely related to the C-
reactive protein and tumor necrosis factor (TNF)-α.
8 Ac-
cording to a recent study, inflammatory response is direc-
tly connected with the initial symptom of arteriosclerosis,
not to mention hyperlipidemia.
9 As such, hyperlipidemia
and inflammatory responses need to be understood coo-
peratively. In this context, the results of this study deserve
attention. 
This research therefore involved rats induced with hy-
perlipidemia through the administration of poloxamer-407
to examine the change in lipid level in blood for each Panax
notoginseng administration level compared with atorvas-
tatin administration. In addition, the interleukin (IL)-1,
TNF-α, cyclo-oxygenase (COX)-2, and intercellular adhe-
sion molecule (ICAM) manifestation level was examined
through immunohistochemistry staining of the abdominal
aorta, drawing significant results for the report. 
Experimental animals
Six-week-old male Wister rats (Orient Co., Seoul, Korea)
were used as experimental animals. They weighed 140 ±
10 g on average. Experimental animals adapted themselves
to the temperature of 22˚C ± 2 and the relative humidity of
60 ± 10% for one week. Light was alternated with dark-
ness at intervals of 12 hours (07:00 a.m-07:00 p.m). Water
and sold feed (Samyang Feed Co., Pyeongtaek, Korea)




Reflux extraction was applied to a round-bottom flask con-
taining 1 kg of Sam-Chil-Geun and 5 liters of distilled
water for 2 hours. The filtrate collected through a 100-
mesh strainer was concentrated at 60˚C by a decompres-
sion concentrator (Eyela NE, Tokyo Rikakikai Co. Ltd.,
Tokyo, Japan). A ropy liquid was thus produced. The
liquid was freeze dried (PVTFD 10A, Ilshin Lab. Co. Ltd.,
Suwon, Korea) and so 118 g of Sam-Chil-Geun extract was
produced (the yield of 11.8%). To the positive control
group, 1.34 mg/kg of Atorvastatin (Lipitor; Pfizer Inc.,
Seoul, Korea) was administered. 
Hyperlipidemia-inducing reagent
Poloxamer-407 (Lutrol F127; BASF, Ludwigshafen, Ger-
many) was used as the hyperlipidemia-inducing reagent.
Experimental methods
Experimental animals were divided into the normal control
group (the normal group), the control group from which
hyperlipidemia was induced by using of poloxamer-407 (P
group), the positive control group to which poloxamer-407
and atorvastatin were administered (P + ST group), the first
experimental group to which poloxamer-407 and 40 mg/kg
of Sam-Chil-Geun extract were administered (P + NG40
group), and the second experimental group to which poloxa-
mer-407 and 100 mg/kg of Sam-Chil-Geun extract were
The Influence of P. notoginseng on Hyperlipidemia in Rats
Yonsei Med J   http://www.eymj.org    Volume 51   Number 4   July 2010 505
MATERIALS AND METHODSadministered (P + NG100 group).
To the normal group, feed and water were unlimitedly
supplied. To the other groups, poloxamer-407 was ad-
ministered at 3 day intervals, from the first day of the ex-
periment until the 21st day. Prior to the administration,
poloxamer-407 was dissolved in saline and was kept refri-
gerated for one day. It was injected into the abdominal
cavity at a dose of 500 mg/kg, between 10:00 a.m and
11:00 a.m. The experimental animals fasted for 6 hours
after the injection.
To the P + ST group, Atorvastatin (Lipitor, Pfizer Inc.,
Seoul, Korea) was orally administered at a dose of 1.34
mg/kg, every day. To the P + NG40 group and the P +
NG100 group, the Sam-Chil-Geun extract (the yield of
11.8%) was orally administered at a dose of 40 mg/kg and
100 mg/kg, respectively, during the same period. The extract
was refrigerated and was defrosted at a concentration of
100 mg/mL prior to the administration by using Dimethyl
Sulfoxide (DMSO). Also, the extract was administered 2
hours after polaxamer-407 was administered.
Measurement of blood-lipid concentration
On the 21st day of the experiment, the ether-inhalation
anesthesia was performed on all experimental animals that
fasted for 12 hours. The etherized animals were again
treated with 75% alcohol, and an abdominal incision was
performed to take blood samples from the ascending
aortas. The blood samples, kept at room temperature for 30
minutes, were centrifuged at a speed of 3,000 revolutions
per minute (RPM) for 15 minutes. The serum, extracted
from the centrifuged samples, was used to analyze the
blood-lipid content.
To every group, total cholesterol, triglyceride, high-
density lipoprotein (HDL)-cholesterol, and LDL-choles-
terol were measured on the basis of the plasma-lipid profile.
A. Total cholesterol
A mixture of 0.02-mililiter serum and 3-mililiter enzyme
solution was heated in a double boiler at 37˚C for 5
minutes. The optical absorbance was measured at a 500-
nanometer wavelength.
B. Triglyceride
A mixture of 0.02-mililiter serum and 3-mililiter reagent
was heated in a double boiler at 37˚C for 5 minutes. The
optical absorbance was measured at a 546-nanometer
wavelength.
C. HDL-cholesterol
A mixture of 1-mililiter serum and 0.1-mililiter precipitant,
kept at room temperature for 5 minutes, was centrifuged
for 10 minutes and the supernatant separated the mixture
for as much as 0.02 mL. The mixture of 0.02-mililiter
supernatant and 0.1-mililiter precipitant, kept at room
temperature for 5 minutes, was centrifuged for 10 minutes.
Again, a mixture of 0.02-mililiter supernatant and 3-
mililiter enzyme solution was heated in a double boiler at
37˚C for 15 minutes. The optical absorbance was measur-
ed at a 500-nanometer wavelength.
D. LDL-cholesterol
The intra-serum LDL-cholesterol level was calculated by
the following formula made by the results of total choles-
terol, triglyceride, and HDL-cholesterol.
“LDL-cholesterol = Total cholesterol-(HDL-cholesterol
+ Triglyceride/5)”
Measurement of IL-1 and TNF-α
Ficoll-Hypague centrifugation was applied to the blood
samples diluted by the same quantity of Hank’s Balanced
Salt Solution (HBSS) for 30 minutes (400 g; 2,500 rpm, 5
mins; 4˚C). 50 microliters of supernatant was kept at
minus 70˚C prior to the measurement. IL-1 and TNF-α
were measured by using a ELISA Kit (Bio Source Interna-
tional Inc., Carlsbad, CA, USA).
Measurement of COX-2 and ICAM-1
On the 21st day of the experiment, the ether-inhalation
anesthesia was performed on all experimental animals that
fasted for 12 hours. On the etherized animals treated with
75% alcohol, an abdominal incision was performed. The
tissue samples (a thickness of 4 micrometers) were obtain-
ed from the ascending aorta to the junction of the left renal
artery. After paraffin was removed by the Bond Dewax
Solution (Vision Bio System, Suwon, Korea), the tissue
section was treated with the Bond ER Solution (Vision Bio
System) at 100˚C for 30 minutes. It was again treated with
hydrogen peroxide for 5 minutes and then reacted with the
COX-2 monoclonal antibody (1 : 100, Dako Cytomation,
Glostrup, Denmark) and the ICAM-1 monoclonal anti-
body (1 : 100, Novacastra Laboratories, Peterborough,
UK) for 15 minutes. The biotin-free polymeric horseradish
peroxidase linker antibody conjugate system of the Bond-
Maxautomatic Slide Strainer (Vision Bio System) was used
in this procedure. Subsequently, it was counterstained with
hematoxylin with glycerin sealed and observed under opti-
cal microscopy.
Statistical analysis
The results of the experiment indicated ‘Mean ± Standard
Deviation’ and the statistical significance of the intergroup
difference (the normal group, P group, P + ST group, P +
NG40 group and P + NG100 group) were verified through a
one-way analysis of variance (ANOVA). 
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The normal group, P group, P + ST group, P + NG40 group,
and P + NG100 group measured an intra-serum total chole-
sterol level of 85.7 ± 4.9 mg/dL, 470.2 ± 52.0 mg/dL,
320.2 ± 77.6 mg/dL, 400.3 ± 64.2 mg/dL, and 451.1 ±
56.1 mg/dL, respectively.
The total cholesterol was significantly lowered in the P +
ST group and the P + NG40 group, as compared with the P
group. The results of the intergroup comparison indicate
that the total cholesterol of the P + ST group was significan-
tly lowered compared to P + NG40 (p < 0.05 in ANOVA
and post-hoc) (Fig. 1).
HDL-cholesterol
The normal group, P group, P + ST group, P + NG40 group
and P + NG100 group measured an intra-serum HDL-
cholesterol level of 25.2 ± 2.6 mg/dL, 38.6 ± 7.3 mg/dL,
40.6 ± 7.3 mg/dL, 37.4 ± 6.3 mg/dL, and 35.2 ± 2.1 mg/dL,
respectively. The intergroup difference was not significant,
as compared to the P group (p< 0.05 in ANOVA) (Fig. 2).
LDL-cholesterol
The normal group, P group, P + ST group, P + NG40
group and P + NG100 group measured an intra-serum
LDL-cholesterol level of 13.7 ± 5.8 mg/dL, 126.5 ± 26.9
mg/dL, 105.0 ± 17.6 mg/dL, 119.2 ± 11.5 mg/dL, and
132.3 ± 17.8 mg/dL, respectively.
The LDL-cholesterol was significantly lowered in the P
+ ST group compared to the P group (p < 0.05 in ANOVA
and post-hoc) (Fig. 3).
Triglyceride
The the normal group, P group, P + ST group, P + NG40
group and P + NG100 group measured an intra-serum
triglyceride level of 51.5 ± 10.6 mg/dL, 1034.5 ± 141.2
mg/dL, 710.8 ± 78.1 mg/dL, 742.8 ± 84.2 mg/dL, and 853.0
± 104.2 mg/dL, respectively.
Triglyceride was significantly lowered in the P + ST
group and P + NG40 group compared to the P group. The
results of the intergroup comparison indicate that the trigly-
ceride of the P + ST group was significantly lowered com-
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RESULTS
Fig. 1. Serum total cholesterol levels in each group. Without any intervention
(normal), poloxamer 500 mg/kg i.p. (P), poloxamer plus atorvastatin 1.34 mg/kg
p.o. (P + ST), poloxamer plus P. notoginseng 40 mg/kg p.o. (P + NG40), and
poloxamer plus P. notoginseng100 mg/kg p.o. (P + NG100) (*p < 0.05, ANOVA &
post-hoc). ANOVA, analysis of variance.
Fig. 2. Serum HDL-cholesterol levels in each group. Without any intervention
(normal), poloxamer 500 mg/kg i.p. (P), poloxamer plus atorvastatin 1.34 mg/kg
p.o. (P + ST), poloxamer plus P. notoginseng 40 mg/kg p.o. (P + NG40), and
poloxamer plus P. notoginseng 100 mg/kg p.o. (P + NG100) (p< 0.05, ANOVA &
post-hoc). ANOVA, analysis of variance.
Fig. 3. Serum LDL-cholesterol levels in each group. Without any intervention
(normal), poloxamer 500 mg/kg i.p. (P), poloxamer plus atorvastatin 1.34 mg/kg
p.o. (P + ST), poloxamer plus P. notoginseng 40 mg/kg p.o. (P + NG40), and
poloxamer plus P. notoginseng 100 mg/kg p.o. (P + NG100) (*p< 0.05, ANOVA &
post-hoc). ANOVA, analysis of variance.
Fig. 4. Serum triglyceride levels in each group. Without any intervention
(normal), poloxamer 500 mg/kg i.p. (P), poloxamer plus atorvastatin 1.34 mg/kg
p.o. (P + ST), poloxamer plus P. notoginseng 40 mg/kg p.o. (P + NG40), and
poloxamer plus P. notoginseng 100 mg/kg p.o. (P + NG100) (*p< 0.05, ANOVA &
post-hoc). ANOVA, analysis of variance.pared to the P + NG100 group (p < 0.05 in ANOVA and
post-hoc) (Fig. 4).
IL-1 and TNF-α α
The intergroup difference was not observed in IL-1 and
TNF-α(p< 0.05 in ANOVA) (Fig. 5).
Immunohistochemically-stained COX-2
The intergroup difference was not observed in COX-2
(Fig. 6).
Immunohistochemically-stained ICAM
The intergroup difference was not observed in ICAM
(Fig. 7).
Hyperlipidemia is largely distinguished into ‘primary’ and
‘secondary’ hyperlipidemia depending on its etiology. It
was reported that primary hyperlipidemia develops when
Il Woo Joo, et al.
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DISCUSSION
Fig. 6. Immunohistochemical COX-2 stained slides in each group (×400).
Without any intervention (normal), poloxamer 500 mg/kg i.p. (P), poloxamer plus
atorvastatin 1.34 mg/kg p.o. (P + ST), poloxamer plus P. notoginseng 40 mg/kg
p.o. (P + NG40), and poloxamer plus P. notoginseng 100 mg/kg p.o. (P + NG100)
(p< 0.05, ANOVA & post-hoc ). COX-2, cyclo-oxygenase-2; ANOVA, analysis of
variance.
Fig. 5. IL-1 (A), TNF-α  (B) levels in each group. Without any intervention (Normal), poloxamer 500 mg/kg i.p. (P), poloxamer plus atorvastatin 1.34 mg/kg p.o. (P + ST),
poloxamer plus P. notoginseng40 mg/kg p.o. (P + NG40), and poloxamer plus P. notoginseng100 mg/kg p.o. (P + NG100) (p< 0.05, ANOVA & post-hoc). IL-1, interleukin-1;
TNF, tumor necrosis factor; ANOVA, analysis of variance.
Normal P
P + ST P + NG40
P + NG100 Sample as a COX-2 (+)
Fig. 7. Immunohistochemical ICAM stained slides in each group (×400).
Without any intervention (Normal), poloxamer 500 mg/kg i.p. (P), poloxamer plus
atorvastatin 1.34 mg/kg p.o. (P + ST), poloxamer plus P. notoginseng 40 mg/kg
p.o. (P + NG40), and poloxamer plus P. notoginseng 100 mg/kg p.o. (P + NG100)
(p < 0.05, ANOVA & post-hoc). ICAM, intercellular adhesion laboratories;
ANOVA, analysis of variance.
Normal P
P + ST P + NG40
P + NG100 Sample as a COX-2 (+)
IL-1 levels in each group TNF-αlevels in each group
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lipoprotein lipase (a type of the enzyme related to lipid
metabolism) is deficient, when cell-membrane LDL recep-
tors are insufficient, when apoprotein CII (a type of lipo-
protein) is deficient, or when apoprotein E is abnormally
produced. Secondary hyperlipidemia develops in relation
to hormonal disorders such as diabetes or hypothyroidism,
alcoholism, the abuse of glucocorticoids, and other dise-
ases of the internal organs that may affect lipid metabolism
(nephrotic syndrome, hepatoma, SLE, etc).
Blood lipid consists of cholesterol, triglyceride, phos-
pholipid, and FFA absorbed from food or synthesized in
vivo. The hydrophobic lipid, bound to hydrophilic apopro-
tein, flows through the blood vessels, in the form of lipo-
protein. Lipoprotein is separated into chylomicron, very
low-density lipoprotein (VLDL), LDL, and HDL according
to the component ratios of triglyceride, cholesterol, and
others. The specific gravity of lipoprotein increases in
proportion to cholesterol but in inverse proportion to trigly-
ceride or protein. VLDL contains a large amount of
triglyceride, and LDL and HDL contains a large amount of
cholesterol. If problems arise in lipoprotein synthesis or
analysis, blood lipids are not normally transported and so
its concentration becomes out of normal range.
Hyperlipidemia is one of the key factors that cause
atherosclerosis in the coronary artery or cerebral blood
vessels, in addition to hypertension, smoking, and obe-
sity.
8-10 The LDL, which was not removed in the process of
lipid metabolism, is apt to flow into the subendothelial
space, as well as to undergo oxidation. The oxidized LDL
is phagocytized by the scavengers of macrophages. This
fat-laden macrophage is left with the lipid core filled with
cholesterol after necrocytosis and then makes arterios-
clerosis.
11 This is the main pathophysiologic factor of
vascular diseases such as angina pectoris, myocardial
infarction, stroke, etc. Thus, it is very important to properly
maintain blood-lipid concentration in the prevention and
early treatment of hyperlipidemia. In particular, LDL-
cholesterol and triglyceride needs to be intensely managed
because the increase of either may bring forth more serious
danger. However, the decrease of HDL-cholesterol may
also be dangerous because it takes part in the removal of
the cholesterol left in cellular tissue.
It was already proven that Sam-Chil-Geun is effective in
preventing platelet aggregation, that it increasesthe blood
flow rate of the coronary artery, it helps the left ventricle to
relax, and it reduces the risk of heart diseases.
12 Also, it
was reported that Sam-Chil-Geun lowers the concentration
of intra-neutrophil free calcium so that inflammations may
be healed.
13 The notoginsenosides of Sam-Chil-Geun
seemed to stimulate tissue-type plasminogen activators in
human endotheliocytes and vascular smooth muscle cells
cultured in the medium, and to deactivate plasminogen
activator inhibitor-1.
14 Prostacyclin synthesis was pro-
moted in the coronary artery of the rats with Sam-Chil-
Geun extract orally administered for 10 days, and throm-
boxane A2 synthesis was deactivated with decrease of
arteriosclerotic plaque.
15
Arteriosclerosis is a response not only to hyperlipidemia
but also to the inflammations of the vessel wall. Such
inflammatory responses can be explained through the
hypofunction of vascular endotheliocytes, the development
of adhesion molecules, and the infiltration of neutrophils,
that is, the monocytes, which infiltrated the arterial intima
and rapidly changed to macrophages.
16-18 NF-kB, cAMP
response element-binding protein (CREB) and activating
protein (AP)-1, which are known as nuclear transcription
factors, call forth pro-inflammatory factors such as COX-2
and TNF-α and IL-1. On the other hand, it is known that
Sam-Chil-Geun inhibits such factors from developing.
19
Another study reported that Sam-Chil-Geun inhibits inflam-
mation-inducing substances such as COX-2, iNOS, and
cell adhesion molecules by the NF-kB pathway.
20 Sam-
Chil-Geun comprehensively consists of about 20 types of
saponin such as ginsenoside Rg1, Rg2, Rb1, Rb2, Rb3,
Rc, Rd, Re, Rh, F2, and notoginsenosides R1, R2, R3, R4,
R6, Fa, Fc, and Fe.
21 However, the mechanism how these
saponins and ginsenoside interact and make effect on lipid
metabolism and inflammatory change has not yet to be
clarified.
As in previous studies,
6-8 hyperlipidemia was artificially
induced from experimental animals by feeding these
animals a high-cholesterol diet. But in this study, Poly-
xamer-407 was administered to make hyperlipidemia and
arteriosclerosis instead of fat diet. Polyxamer-407 is a
block copolymer in which the polyoxyethylene unit is
alternated with a polyoxypropylene unit,
22 and it is known
that the reagent increases neutral fat and cholesterol by at
least 60 times and 8 times, respectively.
23 Lipoprotein
lipase is necessary to hydrolyze the lipoprotein TG of
serum, and an in vitro experiment found that Polyxamer-
407 inhibits lipoprotein lipase. Recent study showed that
the activity of lipoprotein lipase decreased by 95% in the
group to which Polyxamer-407 was administered for 3
hours.
24 In the process of cholesterol synthesis, hepatic 3-
hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)
reductase functions as the main rate-limiting enzyme.
Lovastatin and pravastatin inhibited cholesterol synthesis
by acting as HMG-CoA reductase inhibitors.
25
In the present study, the Sam-Chil-Geun extract was
administered to the rats with hyperlipidemia induced by
the administration of poloxamer-407 in order to ascertain
whether blood-lipid, IL-1, TNF-α, COX-2, and ICAM can
be lowered. In particular, COX-2 and ICAM were immu-
nohistochemically stained in the process of the experiment.Il Woo Joo, et al.
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To the positive control group, Atorvastatin (one of HMG-
CoA reductase inhibitor) was used.
With regards to total cholesterol, the P + ST group and P
+ NG40 group showed a significant decrease compared to
the control group from which hyperlipidemia was artifi-
cially induced (P group). In the results of the intergroup
comparison, the total cholesterol level of the P + ST group
was significantly lowered compared to the P + NG40 group.
In the case of HDL-cholesterol, the intergroup difference
was not significant as compared with the control group
from which hyperlipidemia was artificially induced (P
group). Only the P + ST group showed a significant dec-
rease of LDL cholesterol level. Triglyceride was signifi-
cantly lowered in the P + ST group and P + NG40 group
compared to the control group from which hyperlipidemia
was artificially induced (P group). In the results of the
intergroup comparison, the P + ST group showed a signifi-
cantly lower triglyceride level than the P + NG100 group.
But there was no significant difference of triglyceride level
between the P+ST group and the P + NG40 group. 
Overall, it was found that Sam-Chil-Geun lowers the
total cholesterol level and the triglyceride level. Since there
was no significant difference among the 100 mg/kg, 40
mg/kg of the Sam-Chil-Geun extract and Atorvastatin in
the decrease of triglyceride, there is a possibility that 40
mg/kg may be more effective than 100 mg/kg in the decr-
ease of lipids. The Sam-Chil-Geun needs to be further
researched with subgrouping by its concentration. And we
also suggest the study of combination treatment of the
Sam-Chil-Geun extract and Atorvastatin to maximize the
curative effect of hyperlipidemia and to minimize their
doses according to patient’s symptoms and disease severity
in the near future. 
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